Patriot Scientific

Patriot Scientific Reports Profitable Quarter; Q3 FY '08 Net Income $6.3 Million or $0.02 Basic and Diluted Earnings Per Share.
in response to jldmt's message

outside of our PDS partnership, or without the assistance of Alliasence providing prosecutorial/infringing patent research/workproduct. TPL being our other JV partner, likely doesn't want any revenues that would come from licenses until such time as they negotiate a favorable debt reduction or painlessly stable repayment schedule in BK court.

PTSC is hostage to Alliasence, because as we know, PDS as the Licensing agent of the MMP appears to not be able break the contract with Alliasence; not even for non performance or good cause. Alliasence, being a Leckrone family company, who it seems can terminate the contract even for "convenience", and who owns all the reverse engineering and infringment Work Product, may not want to advance enough support for a license negotiation, or even name an infringing target; regardless if PDS wanted one.

This extreme one sided contract, to a company formerly owned by our JV partner, under the conditions in which it was conducted and executed, is, imo, unconscionable, especially for a public company with only one singular wasting asset that generates 100% of our company's revenues. I believe that aside from the many other curious business decisions made by our BOD, this latest licensing agreement arrangement would not pass Fiduciary muster and would run afoul of the Business Judgement Rule; even from a BOD friendly liberal interpretation State like Delaware.

Please login to post a reply
Biajj2too
City
Rank
Treasurer
Activity Points
4951
Rating
Your Rating
Date Joined
07/23/2012
Social Links
Private Message
Patriot Scientific
Symbol
PTSC
Exchange
OTCBB
Shares
401,392,948
Industry
Technology & Medical
Website
Create a Post